Drug Policies Skyline during COVID-19 Pandemic

The COVID-19 pandemic has produced an extraordinary care setting where physicians played, and continue to play, a critical role in containing viral spread and treating affected patients. Frontline workers have been receiving day-to-day new information about therapeutic advances. The purpose of the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vita, Serena, Forliano, Dora, De Luca, Aldo, Beccacece, Alessia, Marchioni, Luisa, Nicastri, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307413/
https://www.ncbi.nlm.nih.gov/pubmed/34300283
http://dx.doi.org/10.3390/jcm10143117
Descripción
Sumario:The COVID-19 pandemic has produced an extraordinary care setting where physicians played, and continue to play, a critical role in containing viral spread and treating affected patients. Frontline workers have been receiving day-to-day new information about therapeutic advances. The purpose of the study is to analyse COVID-19 drug consumption trends in both acute and intensive care settings comparing Defined Daily Doses and the release of scientific clinical data from January to December 2020.

Ejemplares similares